After Trump Tests Positive, "Doing Well"...Mild Symptoms and Working at Military Hospital (Summary)

Mild Fever, Cough, and Nasal Congestion Symptoms... "Never Transferred Power to the Vice President"

[Asia Economy Reporter Yujin Cho] U.S. President Donald Trump, after testing positive for COVID-19 on the 2nd (local time), is showing mild symptoms but will be hospitalized for a few days at a military hospital as a precautionary measure, the White House announced.

While moving to the military hospital for admission, President Trump gave a thumbs-up to the White House press pool but did not stop for questions. He was seen wearing a navy suit, a blue tie, and a black mask.

In a separate video message posted on Twitter, President Trump said, "I want to thank everyone who has sent their support," adding, "I think I am doing well."

White House Press Secretary Kayleigh McEnany stated in a press release, "President Trump is showing mild symptoms but will continue to work for a few days at Walter Reed (Hospital) as a precautionary measure and under medical advice."

Regarding speculation that President Trump might temporarily transfer power to Vice President Mike Pence as a precaution, a White House official said, "That has not happened."

Earlier that day, President Trump announced via Twitter that he and First Lady Melania Trump had tested positive for COVID-19 and remained at the White House residence.

White House physician Sean Conley said in a statement released in the afternoon, "President Trump is experiencing fatigue but is in good condition," and that as a precaution, he has been taking Regeneron's antibody drug, zinc, vitamin D, melatonin, and aspirin.

Regeneron is a biotechnology company currently conducting Phase 3 clinical trials for its COVID-19 antibody drug, CNN reported.

The Washington Post, citing officials, reported that the president's condition worsened that day, experiencing mild fever, cough, and nasal congestion symptoms.

This content was produced with the assistance of AI translation services.